Finance

Lists
IBRX:NASDAQ
Immunitybio Inc
၆.၅၇ US$
-၁.၉၄%
(-၀.၁၃) 1D
၆.၅၀ US$
-၁.၀၇% (-၀.၀၇၀)
After hours
Closed: နို ၁၉, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBRX...
Open
၆.၇၂ US$
High
၆.၈၃ US$
Low
၆.၄၁ US$
Mkt. cap
၆၉၈.၉၃ ဋေ
Avg. vol.
၁.၄၄ ကုဋေ
Volume
၁.၁၁ ကုဋေ
52-wk high
၁၂.၄၃ US$
52-wk low
၁.၉၅ US$
EPS
-၁.၀၇ US$
Beta
၀.၁၇
Shares outstanding
၁၀၆.၃၈ ဋေ
No. of employees
၆၈၈
Open
၆.၇၂ US$
High
၆.၈၃ US$
Low
၆.၄၁ US$
Mkt. cap
၆၉၈.၉၃ ဋေ
Avg. vol.
၁.၄၄ ကုဋေ
Volume
၁.၁၁ ကုဋေ
52-wk high
၁၂.၄၃ US$
52-wk low
၁.၉၅ US$
EPS
-၁.၀၇ US$
Beta
၀.၁၇
Shares outstanding
၁၀၆.၃၈ ဋေ
No. of employees
၆၈၈
News stories
From web sources and news partners
About Immunitybio Inc
CEORich Adcock
Employees၆၈၈
Founded၂၀၁၄
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to IBRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IBRX in the last 3 months.
Highest
Current ၆.၅၇ US$
၁၆.၀၀ US$ (+၁၄၃.၅၃%)
Average
၁၄.၂၅ US$ (+၁၁၆.၈၉%)
Lowest
၁၂.၀၀ US$ (+၈၂.၆၅%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Maintained
၁၂.၀၀ US$
+၈၂.၆%
11/09/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
၁၅.၀၀ US$
+၁၂၈.၃%
11/09/2026
Kelly Shi
Jefferies
Buy
Maintained
၁၄.၀၀ US$
+၁၁၃.၁%
10/14/2026
Edward Tenthoff
Piper Sandler
Buy
Maintained
၁၆.၀၀ US$
+၁၄၃.၅%
10/14/2026
Last report
၂၀၂၆ နို ၉
Fiscal period
Q3 2026
-၀.၀၉ US$ / -၀.၀၅ US$
-၈၄.၈၀%miss
Revenue / Est. (USD)
၄.၈၈ ကုဋေ / ၅.၉၂ ကုဋေ
-၁၇.၅၃%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၃.၈၃ ကုဋေ
၄.၄၂ ကုဋေ
၅.၁၂ ကုဋေ
၄.၈၈ ကုဋေ
Cost of goods sold
၃.၈၂ သိန်း
၂.၃၈ သိန်း
၂.၉၈ သိန်း
၁.၂၉ သန်း
Cost of revenue
၃.၈၂ သိန်း
၂.၃၈ သိန်း
၂.၉၈ သိန်း
၁.၂၉ သန်း
Research and development expenses
၆.၇၃ ကုဋေ
၆.၈၀ ကုဋေ
၆.၀၈ ကုဋေ
၇.၁၃ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၅၃ ကုဋေ
၄.၅၈ ကုဋေ
၅.၁၈ ကုဋေ
၅.၄၂ ကုဋေ
Operating expense
၁၀.၂၆ ကုဋေ
၁၁.၃၈ ကုဋေ
၁၁.၂၆ ကုဋေ
၁၂.၅၅ ကုဋေ
Total operating expenses
၁၀.၃၀ ကုဋေ
၁၁.၄၀ ကုဋေ
၁၁.၂၉ ကုဋေ
၁၂.၆၈ ကုဋေ
Operating income
-၆.၄၇ ကုဋေ
-၆.၉၈ ကုဋေ
-၆.၁၇ ကုဋေ
-၇.၈၀ ကုဋေ
Other non operating income
၂.၇၅ ကုဋေ
-၅၂.၉၄ ကုဋေ
-၁၄.၀၆ ကုဋေ
-၇.၇၇ ကုဋေ
EBT including unusual items
-၆.၂၁ ကုဋေ
-၆၃.၂၈ ကုဋေ
-၂၃.၀၄ ကုဋေ
-၁၈.၄၆ ကုဋေ
EBT excluding unusual items
-၆.၂၁ ကုဋေ
-၆၂.၅၄ ကုဋေ
-၂၃.၀၄ ကုဋေ
-၁၈.၄၆ ကုဋေ
Income tax expense
-၁.၃၅ သိန်း
၉.၀၀ ထောင်
-
-
Effective tax rate
၀.၂၂%
-
-
-
Other operating expenses
-
-
-
-
Net income
-၆.၁၉ ကုဋေ
-၆၃.၂၈ ကုဋေ
-၂၃.၀၄ ကုဋေ
-၁၈.၄၆ ကုဋေ
Net profit margin
-၁၆၁.၈၀%
-၁,၄၃၁.၄၄%
-၄၄၉.၆၁%
-၃၇၇.၈၆%
Earnings per share
-၀.၀၆
-၀.၀၈
-၀.၂၂
-၀.၀၉
Interest and investment income
၂.၃၀ သန်း
၂.၃၁ သန်း
၃.၁၆ သန်း
၃.၁၇ သန်း
Interest expense
-၂.၇၂ ကုဋေ
-၂.၈၅ ကုဋေ
-၃.၁၂ ကုဋေ
-၃.၂၀ ကုဋေ
Net interest expenses
-၂.၄၉ ကုဋေ
-၂.၆၂ ကုဋေ
-၂.၈၁ ကုဋေ
-၂.၈၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၆.၀၉ ကုဋေ
-၆.၅၄ ကုဋေ
-၅.၇၃ ကုဋေ
-၇.၄၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ